UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2854-2860

2013

Volltextzugriff (PDF)

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

BMC cancer, 2013-01, Vol.13 (1), p.22-22, Article 22

2013

Volltextzugriff (PDF)

Induction Chemotherapy Before Chemoradiotherapy in Locally Advanced Head and Neck Cancer: The Future?

The oncologist (Dayton, Ohio), 2010-10, Vol.15 (S3), p.8-12

2010

Volltextzugriff (PDF)

The Role of Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Seminars in radiation oncology, 2012-07, Vol.22 (3), p.198-206

2012

Volltextzugriff (PDF)

Adding Gemcitabine to Paclitaxel/Carboplatin Combination Increases Survival in Advanced Non–Small-Cell Lung Cancer: Results of a Phase II-III Study

Journal of clinical oncology, 2006-02, Vol.24 (4), p.681-687

2006

Volltextzugriff (PDF)

Therapeutic Intensification and Induction Chemotherapy for High-Risk Locally Advanced Squamous Cell Carcinoma

Current treatment options in oncology, 2019-01, Vol.20 (1), p.2-15, Article 2

2019

Volltextzugriff (PDF)

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non–Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

JNCI : Journal of the National Cancer Institute, 2007-06, Vol.99 (11), p.847-857

2007

Volltextzugriff (PDF)

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck

Anti-cancer drugs, 2004-04, Vol.15 (4), p.331-340

2004

Volltextzugriff (PDF)

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study

International journal of radiation oncology, biology, physics, 2004-06, Vol.59 (2), p.481-487

2004

Volltextzugriff (PDF)

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874]

BMC cancer, 2006-02, Vol.6 (1), p.44-44, Article 44

2006

Volltextzugriff (PDF)

Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

JNCI : Journal of the National Cancer Institute, 2004-11, Vol.96 (22), p.1714-1717

2004

Volltextzugriff (PDF)

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: A multicentric Phase II study

Cancer, 2003-06, Vol.97 (11), p.2791-2797

2003

Volltextzugriff (PDF)

A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.6003-6003

2013

Volltextzugriff (PDF)

P-587 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclitaxel (CP) and radiation therapy in unresectable stage III NSCLC

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S239-S239

2003

Volltextzugriff (PDF)

Phase III Trial of Initial Chemotherapy in Stage III or IV Head and Neck Cancers: a Study by the Gruppo di Studio sui Tumori della Testa e del Collo

JNCI : Journal of the National Cancer Institute, 1994-02, Vol.86 (4), p.265-272

1994

Volltextzugriff (PDF)

Long term results of surgery and chemotherapy in small cell lung cancer1

European journal of cardio-thoracic surgery, 1998-10, Vol.14 (4), p.398-402

1998

Volltextzugriff (PDF)

Normal-release Oral Morphine Starting Dose in Cancer Patients With Pain

The Clinical journal of pain, 2009-06, Vol.25 (5), p.386-390

2009

Volltextzugriff (PDF)

The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during ‘titration phase’ in patients with cancer pain

Palliative medicine, 2008-04, Vol.22 (3), p.214-221

2008

Volltextzugriff (PDF)

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

Lung cancer (Amsterdam, Netherlands), 2004, Vol.43 (1), p.83-91

2004

Volltextzugriff (PDF)

Long term results of surgery and chemotherapy in small cell lung cancer

European journal of cardio-thoracic surgery, 1998-10, Vol.14 (4), p.398-402

1998

Volltextzugriff (PDF)

A3-01: Correlation of tumor response and survival in advanced NSCLC patients treated with Paclitaxel plus Carboplatin (PC) vs Paclitaxel plus Carboplatin plus Gemcitabine (PCG)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S315-S316

2007

Volltextzugriff (PDF)

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer : Results of a phase II-II study

Journal of clinical oncology, 2006, Vol.24 (4), p.681-687

2006

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(54)

Sprache

Englisch
(53)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(39)
Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Oncology
(32)
Female
(31)
Middle Aged
(30)
Male
(29)
Aged
(28)
Adult
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(25)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Cisplatin - Administration & Dosage
(17)
Chemotherapy
(16)
Antineoplastic Agents
(13)
Pharmacology. Drug Treatments
(13)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(12)
Treatment Outcome
(11)
Lung Neoplasms - Drug Therapy
(10)
Carcinoma, Squamous Cell - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

Induction Chemotherapy Before Chemoradiotherapy in Locally Advanced Head and Neck Cancer: The Future?

The Role of Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Adding Gemcitabine to Paclitaxel/Carboplatin Combination Increases Survival in Advanced Non–Small-Cell Lung Cancer: Results of a Phase II-III Study

Therapeutic Intensification and Induction Chemotherapy for High-Risk Locally Advanced Squamous Cell Carcinoma

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non–Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874]

Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: A multicentric Phase II study

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826)

A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826)

P-587 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclitaxel (CP) and radiation therapy in unresectable stage III NSCLC

Phase III Trial of Initial Chemotherapy in Stage III or IV Head and Neck Cancers: a Study by the Gruppo di Studio sui Tumori della Testa e del Collo

Long term results of surgery and chemotherapy in small cell lung cancer1

Normal-release Oral Morphine Starting Dose in Cancer Patients With Pain

The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during ‘titration phase’ in patients with cancer pain

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

Long term results of surgery and chemotherapy in small cell lung cancer

A3-01: Correlation of tumor response and survival in advanced NSCLC patients treated with Paclitaxel plus Carboplatin (PC) vs Paclitaxel plus Carboplatin plus Gemcitabine (PCG)

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer : Results of a phase II-II study

Suchergebnisse filtern